135 related articles for article (PubMed ID: 12871518)
1. Two new antithrombin variants support a role for K114 and R13 in heparin binding.
Picard V; Susen S; Bellucci S; Aiach M; Alhenc-Gelas M
J Thromb Haemost; 2003 Feb; 1(2):386-7. PubMed ID: 12871518
[No Abstract] [Full Text] [Related]
2. Antithrombin and heparin.
Carrell R; Skinner R; Warden M; Whisstock J
Mol Med Today; 1995 Aug; 1(5):226-31. PubMed ID: 17607884
[TBL] [Abstract][Full Text] [Related]
3. Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin binding.
Chowdhury V; Mille B; Olds RJ; Lane DA; Watton J; Barrowcliffe TW; Pabinger I; Woodcock BE; Thein SL
Br J Haematol; 1995 Mar; 89(3):602-9. PubMed ID: 7734360
[TBL] [Abstract][Full Text] [Related]
4. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
[TBL] [Abstract][Full Text] [Related]
5. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
Arocas V; Turk B; Bock SC; Olson ST; Björk I
Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
[TBL] [Abstract][Full Text] [Related]
6. Importance of lysine 125 for heparin binding and activation of antithrombin.
Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
[TBL] [Abstract][Full Text] [Related]
7. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
8. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
Dewerchin M; Hérault JP; Wallays G; Petitou M; Schaeffer P; Millet L; Weitz JI; Moons L; Collen D; Carmeliet P; Herbert JM
Circ Res; 2003 Nov; 93(11):1120-6. PubMed ID: 14592998
[TBL] [Abstract][Full Text] [Related]
10. The molecular genetics of antithrombin deficiency.
Olds RJ; Lane DA; Thein SL
Br J Haematol; 1994 Jun; 87(2):221-6. PubMed ID: 7947262
[No Abstract] [Full Text] [Related]
11. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.
Beauchamp NJ; Pike RN; Daly M; Butler L; Makris M; Dafforn TR; Zhou A; Fitton HL; Preston FE; Peake IR; Carrell RW
Blood; 1998 Oct; 92(8):2696-706. PubMed ID: 9763552
[TBL] [Abstract][Full Text] [Related]
12. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of antithrombin strand 1C substitution mutations.
Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
[TBL] [Abstract][Full Text] [Related]
14. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin histidine variants 1H NMR resonance assignments and functional properties.
Fan B; Turko IV; Gettins PG
FEBS Lett; 1994 Oct; 354(1):84-8. PubMed ID: 7957907
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding.
Borg JY; Brennan SO; Carrell RW; George P; Perry DJ; Shaw J
FEBS Lett; 1990 Jun; 266(1-2):163-6. PubMed ID: 2365065
[TBL] [Abstract][Full Text] [Related]
17. Insight into residues critical for antithrombin function from analysis of an expanded database of sequences that includes frog, turtle, and ostrich antithrombins.
Backovic M; Gettins PG
J Proteome Res; 2002; 1(4):367-73. PubMed ID: 12645893
[TBL] [Abstract][Full Text] [Related]
18. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
19. Role of protein conformational changes, surface approximation and protein cofactors in heparin-accelerated antithrombin-proteinase reactions.
Olson ST; Björk I
Adv Exp Med Biol; 1992; 313():155-65. PubMed ID: 1442259
[No Abstract] [Full Text] [Related]
20. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
